Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG-PET/CT external beam radiation treatment planning in lung cancer

Affiliations

• ¹ Nuclear Medicine-Radiopharmacology Champalimaud Foundation and Leiden University Medical Center, Lisbon, Portugal. Electronic address: [email protected].
• ² Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands. Electronic address: [email protected].
• ³ Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logroño (La Rioja), Spain.
• ⁴ Henri Becquerel Cancer Center, QuantIF-LITIS EA 4108, Université de Rouen, Rouen, France. Electronic address: [email protected].
• ⁵ Department of Radiation Oncology (MAASTRO), GROW - School for Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: [email protected].
• ⁶ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany. Electronic address: [email protected].
• ⁷ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: [email protected].
• ⁸ Radiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium. Electronic address: [email protected].
• ⁹ Nuclear Medicine Department, CUF Descobertas Hospital, Lisbon, Portugal.
• ¹⁰ Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: [email protected].
• ¹¹ Department of Radiotherapy and Medical Physics, Centre Henri Becquerel, Rouen, France; QuantIF-LITIS EA4108, University of Rouen, France. Electronic address: [email protected].
• ¹² LaTIM, INSERM, UMR1101, Brest, France. Electronic address: [email protected].
• ¹³ Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany, and Helmholtz Association/Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: [email protected].
• ¹⁴ Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: [email protected].